| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Dermatology (Y.Y., C.L., L.M.), Department of Medicine and Department of Molecular Biology and Pharmacology (L.M.), Washington University School of Medicine, St. Louis, Missouri 63110
Address all correspondence and requests for reprints to: Liang Ma, Division of Dermatology, Department of Medicine, Washington University School of Medicine, Campus Box 8123, 660 South Euclid Avenue, St. Louis, Missouri 63110. E-mail: lima{at}im.wustl.edu.
In utero exposure to diethylstilbestrol (DES) leads to patterning defects in the female reproductive tract (FRT) and a propensity to the development of vaginal adenocarcinomas in humans. In the mouse, DES treatment similarly induces a plethora of FRT developmental defects, including stratification of uterine epithelium and presence of glandular tissue in cervix and vagina. Uterine abnormalities are associated with repression of the homeobox gene Msx2, and DES leads to an altered uterine response in Msx2 mutants including a dilated uterine lumen. Here we investigate the role of Msx2 in normal vaginal development and in FRT response to DES. During vaginal development, Msx2 is required for Tgfß2 and Tgfß3 expression and for proper vaginal epithelial differentiation. Moreover, Msx2 is involved in caudal Wolffian duct regression by promoting apoptosis. Consistently, neonatal DES exposure represses Msx2 expression in the Wolffian duct epithelium and inhibits its apoptosis and subsequent regression. Intriguingly, although DES treatment also represses Msx2 expression in the vaginal epithelium, a much more severe DES-induced vaginal phenotype was observed in Msx2 mutant mice, including a complete failure of Müllerian vaginal epithelial stratification and a severely dilated vaginal lumen, accompanied by loss of p63 and water channel protein expression. These results demonstrate a critical role for Msx2 in counteracting the effect of DES on FRT patterning and suggest that the response to DES may be highly variable depending on the genotype of an individual.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
C. Lin, Y. Yin, G. M. Veith, A. V. Fisher, F. Long, and L. Ma Temporal and spatial dissection of Shh signaling in genital tubercle development Development, December 1, 2009; 136(23): 3959 - 3967. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lin, Y. Yin, F. Long, and L. Ma Tissue-specific requirements of {beta}-catenin in external genitalia development Development, August 15, 2008; 135(16): 2815 - 2825. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yin, W.-W. Huang, C. Lin, H. Chen, A. MacKenzie, and L. Ma Estrogen Suppresses Uterine Epithelial Apoptosis by Inducing Birc1 Expression Mol. Endocrinol., January 1, 2008; 22(1): 113 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Peden, E. Kimberly, K. Gengyo-Ando, S. Mitani, and D. Xue Control of sex-specific apoptosis in C. elegans by the BarH homeodomain protein CEH-30 and the transcriptional repressor UNC-37/Groucho Genes & Dev., December 1, 2007; 21(23): 3195 - 3207. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |